References
- Akagiri S, Naito Y, Ichikawa H, et al. (2008). A mouse model of metabolic syndrome; increase in visceral adipose tissue precedes the development of fatty liver and insulin resistance in high-fat diet-fed male KK/Ta mice. J Clin Biochem Nutr 42:150–7
- Arunkumar E, Anuradha CV. (2012). Genistein promotes insulin action through adenosine monophosphate-activated protein kinase activation and p70 ribosomal protein S6 kinase 1 inhibition in the skeletal muscle of mice fed a high energy diet. Nutr Res 32:617–25
- Folch J, Lees M, Sloane Stanley GH. (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509
- Hwahng SH, Ki SH, Bae EJ, et al. (2009). Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology 49:1913–25
- Hwang JT, Park IJ, Shin JI, et al. (2005). Genistein, EGCG, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 338:694–9
- Kondo T, Kishi M, Fushimi T, Kaga T. (2009). Acetic acid upregulates the expression of genes for fatty acid oxidation enzymes in liver to suppress body fat accumulation. J Agric Food Chem 57:5982–6
- Liu YF, Herschkovitz A, Boura-Halfon S, et al. (2004). Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Mol Cell Biol 24:9668–81
- Lowry OH, Rosebrough N, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–75
- Mandard S, Müller M, Kersten S. (2004). Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61:393–416
- Mohamed Salih S, Nallasamy P, Muniyandi P, et al. (2009). Genistein improves liver function and attenuates nonalcoholic fatty liver disease in a rat model of insulin resistance. J Diabetes 1:278–87
- Oosterveer MH, van Dijk TH, Tietge UJ, et al. (2009). High fat feeding induces hepatic fatty acid elongation in mice. PLoS One 4:e6066
- Ouali F, Djouadi F, Merlet-Bénichou C, et al. (2000). Regulation of fatty acid transport protein and mitochondrial and peroxisomal beta-oxidation gene expression by fatty acids in developing rats. Pediatr Res 48:691–6
- Rijzewijk LJ, van der Meer RW, Lubberink M, et al. (2010). Liver fat content in type 2 diabetes: Relationship with hepatic perfusion and substrate metabolism. Diabetes 59:2747–54
- Saltiel AR, Kahn CR. (2001). Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799–806
- Schultz JR, Tu H, Luk A, et al. (2000). Role of LXRs in control of lipogenesis. Genes Dev 14:2831–8
- Shimano H. (2000). Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver. Trends Cardiovasc Med 10:275–8
- Soh JR, Shin DH, Kwon DY, Cha YS. (2008). Effect of Cheonggukjang supplementation upon hepatic acyl-CoA synthase, carnitine palmitoyltransferase I, acyl-CoA oxidase and uncoupling protein 2 mRNA levels in C57BL/6J mice fed with high fat diet. Genes Nutr 2:365–9
- Thirunavukkarasu V, Anitha Nandhini AT, Anuradha CV. (2004). Effect of alpha-lipoic acid on lipid profile in rats fed a high-fructose diet. Exp Diabesity Res 5:195–200
- Tremblay F, Brûlé S, Hee Um S, et al. (2007). Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc Natl Acad Sci USA 104:14056–61
- Um SH, D’Alessio D, Thomas G. (2006). Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab 3:393–402
- Yap F, Craddock L, Yang J. (2011). Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int J Biol Sci 7:645–50
- Yki-Järvinen H, Westerbacka J. (2005). The fatty liver and insulin resistance. Curr Mol Med 5:287–95
- Zhang BB, Zhou G, Li C. (2009). AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab 9:407–16